Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07279558 · ClinicalTrials.gov registry record · Phase 2
Cannabidiol and Alcohol Use Disorder Phenotypes
A Phase 2 study, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT07279558 is a Phase 2 study that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 150 participants.
The verdict
NCT07279558, a Phase 2 study, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The goal of this study is to learn how CBD affects drinking in people who drink alcohol regularly. Researchers want to see if CBD can help people drink less and reduce problems related to alcohol use.
Interventions
- DRUG Placebo
- DRUG Full-Spectrum Cannabidiol (CBD)
- DRUG Broad-Spectrum Cannabidiol (CBD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2029-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07279558
The ClinicalTrials.gov registry entry for NCT07279558 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07279558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07279558 about?
NCT07279558 is a clinical study titled "Cannabidiol and Alcohol Use Disorder Phenotypes". The goal of this study is to learn how CBD affects drinking in people who drink alcohol regularly. Researchers want to see if CBD can help people drink less and reduce problems related to alcohol use.
What is the current status of trial NCT07279558?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2026-03-31. Estimated completion is 2029-08-31.
What interventions are being tested in trial NCT07279558?
The interventions under investigation include: Placebo (DRUG), Full-Spectrum Cannabidiol (CBD) (DRUG), Broad-Spectrum Cannabidiol (CBD) (DRUG).
Who is sponsoring clinical trial NCT07279558?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.